1. Home
  2. Live Updates
  3. Tonix pharmaceuticals

Live Breaking News & Updates on Tonix pharmaceuticals

Stay informed with the latest breaking news from Tonix pharmaceuticals on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Tonix pharmaceuticals and stay connected to the pulse of your community

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dawson-james , Zembrace-symtouch , Tonix-pharmaceuticals-stock-performance , Nasdaq , Sabby-management , News-ratings-for-tonix-pharmaceuticals-daily , Tonix-pharmaceuticals , Tonix-pharmaceuticals-holding-corp , Free-report , Get-free-report , Tonix-pharmaceuticals-holding , Pharmaceuticals-holding-corp

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Dawson-james , Zembrace-symtouch , Tonix-pharmaceuticals-stock , Exchange-commission , Nasdaq , Sabby-management , News-ratings-for-tonix-pharmaceuticals-daily , Tonix-pharmaceuticals , Tonix-pharmaceuticals-holding-corp , Free-report , Get-free-report , Tonix-pharmaceuticals-holding

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com

Tonix Pharmaceuticals (NASDAQ:TNXP) Coverage Initiated at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Dawson-james , Zembrace-symtouch , Tonix-pharmaceuticals-trading-down , Tonix-pharmaceuticals-holding-corp , Millennium-management , Raymond-james-associates , News-ratings-for-tonix-pharmaceuticals-daily , Tonix-pharmaceuticals , Tonix-pharmaceuticals-company-profile , Virtu-financial , Get-free-report , Pharmaceuticals-trading-down

Tonix Pharmaceuticals (NASDAQ:TNXP) Releases Earnings Results

Tonix Pharmaceuticals (NASDAQ:TNXP) Releases Earnings Results
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Zembrace-symtouch , Dawson-james , Tonix-pharmaceuticals-holding-corp , Blackrock-inc , Institutional-investors-weigh-in-on-tonix-pharmaceuticals , Tonix-pharmaceuticals-price-performance , Armistice-capital , News-ratings-for-tonix-pharmaceuticals-daily , Tonix-pharmaceuticals , Earnings-history-for-tonix-pharmaceuticals , Renaissance-technologies , Northern-trust-corp

TNXP Stock Earnings: Tonix Pharmaceuticals Beats EPS, Misses Revenue for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips TNXP stock results show that Tonix Pharmaceuticals beat analyst estimates for earnings per…

Tonix-pharmaceuticals-beats , Tonix-pharmaceuticals , Market-news , Stock-advice , Misses-revenue , News , Ggregator , Reaking-news , Uration , Edia ,

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Belgium , Massachusetts , United-states , University-of-washington , Washington , Chatham , Michigan , Japan , New-bedford , China , Congo , Taiwan

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

Belgium , Japan , China , National-institutes-of-health , Maryland , United-states , New-bedford , Massachusetts , Hong-kong , Brussels , Bruxelles-capitale , Congo

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Sees Significant Increase in Short Interest

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP – Get Free Report) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 967,000 shares, a growth of 56.9% from the February 29th total of 616,200 shares. Approximately 1.2% of the shares of the company are short sold. […]

Zembrace-symtouch , Dawson-james , Renaissance-technologies , Geode-capital-management , Tonix-pharmaceuticals-holding-corp , Tonix-pharmaceuticals-trading-down , Virtu-financial , Nasdaq , News-ratings-for-tonix-pharmaceuticals-daily , Tonix-pharmaceuticals , Hedge-funds-weigh-in-on-tonix-pharmaceuticals , Tonix-pharmaceuticals-company-profile

Tonix Pharmaceuticals (NASDAQ:TNXP) Receives New Coverage from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note released on Tuesday. The brokerage issued a sell rating on the stock. Separately, Dawson James started coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 price target for the […]

Dawson-james , Zembrace-symtouch , Tonix-pharmaceuticals-holding-corp , Sabby-management , Geode-capital-management , Institutional-investors-weigh-in-on-tonix-pharmaceuticals , Tonix-pharmaceuticals-stock-down , Tonix-pharmaceuticals , Jpmorgan-chase-co , Tonix-pharmaceuticals-company-profile , News-ratings-for-tonix-pharmaceuticals-daily , Armistice-capital

Tonix Pharmaceuticals (NASDAQ:TNXP) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Tonix Pharmaceuticals (NASDAQ:TNXP – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the stock. Separately, Dawson James assumed coverage on Tonix Pharmaceuticals in a report on Wednesday, February 28th. They set a buy rating and a $3.00 target […]

Dawson-james , Zembrace-symtouch , Tonix-pharmaceuticals-holding-corp , Jpmorgan-chase-co , Tonix-pharmaceuticals-price-performance , News-ratings-for-tonix-pharmaceuticals-daily , Hedge-funds-weigh-in-on-tonix-pharmaceuticals , Raymond-james-associates , Tonix-pharmaceuticals , Virtu-financial , Free-report , Sigma-investments